• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Quinolone/ureidopenicillin cross-resistance.

作者信息

Piddock L J, Wijnands W J, Wise R

出版信息

Lancet. 1987 Oct 17;2(8564):907. doi: 10.1016/s0140-6736(87)91387-0.

DOI:10.1016/s0140-6736(87)91387-0
PMID:2889094
Abstract
摘要

相似文献

1
Quinolone/ureidopenicillin cross-resistance.
Lancet. 1987 Oct 17;2(8564):907. doi: 10.1016/s0140-6736(87)91387-0.
2
Enoxacin in lower respiratory tract infections.
J Antimicrob Chemother. 1986 Dec;18(6):719-27. doi: 10.1093/jac/18.6.719.
3
The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").用羧苄青霉素（“羧苄西林”）治疗铜绿假单胞菌感染。
Med J Aust. 1968 Nov 16;2(20):890-5. doi: 10.5694/j.1326-5377.1968.tb83274.x.
4
[Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].[依诺沙星和环丙沙星：对肠杆菌科细菌、铜绿假单胞菌和金黄色葡萄球菌的体外作用]
Med Clin (Barc). 1986 Jan 11;86(1):1-3.
5
R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.R因子、β-内酰胺酶与耐羧苄青霉素的铜绿假单胞菌
Lancet. 1971 Aug 14;2(7720):342-4. doi: 10.1016/s0140-6736(71)90060-2.
6
[Characteristics of the anti-Pseudomonas aeruginosa activity of ureidopenicillins and recent advances in their research].
Zhonghua Nei Ke Za Zhi. 1989 Jun;28(6):332-5.
7
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.诺氟沙星、环丙沙星、依诺沙星和萘啶酸对从住院感染患者中分离出的423株革兰氏阴性杆菌和葡萄球菌的体外比较活性。
J Antimicrob Chemother. 1986 Jan;17(1):63-7. doi: 10.1093/jac/17.1.63.
8
An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:97-103. doi: 10.1093/jac/21.suppl_b.97.
9
[Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
Rev Clin Esp. 1998 Sep;198 Suppl 2:51-61.
10
Carbenicillin in treatment of severe infections due to pseudomonas.羧苄青霉素治疗铜绿假单胞菌引起的严重感染。
J Infect Dis. 1970 Sep;122:Suppl:S96+. doi: 10.1093/infdis/122.supplement_1.s96.

引用本文的文献

1
IN VITRO COMPARATIVE ACTIVITY OF EIGHT ANTIPSEUDOMONAL AGENTS.八种抗假单胞菌药物的体外比较活性
Med J Armed Forces India. 1994 Jul;50(3):193-195. doi: 10.1016/S0377-1237(17)31058-4. Epub 2017 Jun 27.
2
Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa.两种外排系统在多重耐药铜绿假单胞菌中同时表达。
Antimicrob Agents Chemother. 2000 Oct;44(10):2861-4. doi: 10.1128/AAC.44.10.2861-2864.2000.
3
Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.铜绿假单胞菌中多药耐药外排基因oprM的保守性
Antimicrob Agents Chemother. 1997 Apr;41(4):853-6. doi: 10.1128/AAC.41.4.853.
4
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.新型碳青霉烯类药物比阿培南与亚胺培南、美罗培南及其他广谱β-内酰胺类药物的抗菌活性比较。
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):384-91. doi: 10.1007/BF01964439.
5
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.铜绿假单胞菌中的多重抗生素耐药性：外排操纵子参与的证据。
J Bacteriol. 1993 Nov;175(22):7363-72. doi: 10.1128/jb.175.22.7363-7372.1993.
6
Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.铜绿假单胞菌和金黄色葡萄球菌中的喹诺酮耐药性。治疗期间的发展及临床意义。
Infection. 1994;22 Suppl 2:S111-21. doi: 10.1007/BF01793575.
7
Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.铜绿假单胞菌在连续暴露于氟喹诺酮类药物后多重耐药（Mar）突变体的产生。
Antimicrob Agents Chemother. 1995 Feb;39(2):489-95. doi: 10.1128/AAC.39.2.489.
8
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
9
Emergence of bacterial resistance to cefamandole in vivo due to outer membrane protein deficiency.
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):776-8. doi: 10.1007/BF01975046.
10
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.依诺沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004.